Daiwa Securities Group Inc. - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 91 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 6.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$01010.0%0.00%
Q1 2022$01010.0%0.00%
Q4 2021$01010.0%0.00%
Q3 2021$0
-100.0%
1010.0%0.00%
Q2 2021$1,0000.0%1010.0%0.00%
Q1 2021$1,0000.0%1010.0%0.00%
Q4 2020$1,000
-50.0%
101
-62.6%
0.00%
Q3 2020$2,0000.0%2700.0%0.00%
Q2 2020$2,0000.0%2700.0%0.00%
Q1 2020$2,0000.0%2700.0%0.00%
Q4 2019$2,000
-33.3%
2700.0%0.00%
Q3 2019$3,000
+50.0%
270
+22.7%
0.00%
Q2 2019$2,0000.0%2200.0%0.00%
Q1 2019$2,0002200.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 881,450$5,677,0001.32%
IFP Advisors, Inc 50$1,0000.00%
Ten Capital Wealth Advisors, LLC 219$1,0000.00%
View complete list of SYROS PHARMACEUTICALS INC shareholders